Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest Diagnostics

This article was originally published in The Gray Sheet

Executive Summary

Settlement of laboratory test billing fraud charges includes payment of $13.1 mil. The Department of Justice alleged Nichols Institute, acquired by Quest in 1994, illegally billed Medicare, Medicaid, TRICARE, the Department of Defense, and Federal Employees Health Benefits Program from 1989 to 1995 - charging separately for groups of lab tests in order to get a higher reimbursement payment. The settlement is a result of the government's interagency LABSCAM operation, which has recovered $850 mil. in fraudulent payments to date

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel